期刊文献+

血浆脑钠肽水平在不同类型冠心病中的变化及其临床意义 被引量:1

Clinical significance of plasma brain natriuretic peptide in patients with different types of coronary heart disease
原文传递
导出
摘要 目的探讨血浆脑钠肽(BNP)在不同类型冠心病(CHD)中的变化及其临床意义。方法选取已行冠状动脉造影确诊为冠心病患者100例,根据患者临床表现分为急性心肌梗死组(AMI组,30例)、稳定型心绞痛组(SAP组,28例)、不稳定型心绞痛组(UAP组,42例)。另选取同期冠状动脉造影正常的健康人20例为健康对照组。分析各组BNP水平的差异。结果 AMI组BNP水平较UAP组升高[(543.45±22.43)ng/L比(190.42±11.21)ng/L],UAP组BNP水平较SAP组升高[(190.42±11.21)ng/L比(32.34±5.23)ng/L],差异有统计学意义(P<0.05)。SAP组BNP水平与健康对照组比较差异未见统计学意义[(32.34±5.23)ng/L比(31.68±5.32)ng/L]。结论 BNP参与冠心病的发生及发展,并对冠心病的诊断治疗和危险分级有一定的指导意义。 Objective To investigate the changes of plasma brain natriuretic peptide (BNP) in dif- ferent types of coronary heart disease and its clinical significance. Methods One hundred patients with coro- nary angiography diagnosed as coronary heart disease (CHD) were selected as coronary heart disease group, and 20 healthy patients with normal coronary angiography were selected as control group. The patients in coro- nary heart disease group were divided into acute myocardial infarction group (30 cases), stable angina pecto- ris group (28 cases) and unstable angina group (42 cases) according to the clinical manifestations. The differences of BNP levels were studied. Results The level of BNP in AMI group was significantly higher than that of UAP group[ (543. 45±22. 43 )ng/L vs. ( 190. 42 +_ 11.21 ) ng/L) ]. The level of BNP in UAP group was significantly higher than that of the SAP group [ ( 190. 42 ± 11.21 ) ng/L vs (32. 34 ± 5.23 ) ng/L) ], the differences were significant (P 〈 0. 05 ). There was no significant difference in BNP level between the stable angina group and the control group { ( 32. 34 ± 5.23 ) ng/L vs. ( 31.68 ± 5.32 ) ng/L ) ]. Conclusion BNP is involved in the development and progression of coronary heart disease and has some significance for the diagnosis and treatment of coronary heart disease and risk stratification.
出处 《临床医学》 CAS 2017年第11期39-41,共3页 Clinical Medicine
关键词 脑钠肽 冠心病 心肌梗死 Brain natriuretic peptide Coronary atherosclerotic heart disease Myocardial infarction
  • 相关文献

参考文献3

二级参考文献27

  • 1Kelly D, Squire IB, Khan SQ, et al. C -terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial irffaretion [J].J Card Fail, 2008, 14 (9): 739-745.
  • 2Neuhold S, Huelsmann M, Strunk G, et al. Comparison of copeptin, B - type natriuretic peptide, and amino - terminal pro - B - type natriuretic peptide in patients with chronic heart failure : prediction of death at different stages of the disease [J]. J Am Coil Cardiol, 2008, 52 (4) : 266 -272.
  • 3Palazzuoli A, Deckers J, Calabro A, et al. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non - ST - elevation coronary syndromes and preserved systolic function [ J]. Am J Cardiol, 2006, 28 (10): 1322-1328.
  • 4Galvani M, Ferrini D, Ottani F, et al. Natriuretic peptides for risk stratification of patients with acute coronary syndromes [ J ]. Eur J Heart Fail, 2004, 6 (3): 327-333.
  • 5Khan SQ, Dhillon QS, O'Brien RJ, et al. C - Terminal pro - vasopressin (Copeptin) as a novel and prognostic marker in acute myocardial infarction Leicester acute myocardial infarction peptide (LAMP) study [J]. Circulation, 2007, 115 (16): 2103-2110.
  • 6Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983, 51 (3) : 606.
  • 7Foote RS, Pearlman JD, Siegel AH, et al. Detection of exercise induced ischemia by changes in B -type natriuretic peptides [J].J Am Coll Cardiol, 2004, 44 (10) : 1980 -1987.
  • 8Tousouhs D, Kampoli AM, Stefanadi E, et al. New biochemical markers in acute coronary syndromes [ J]. Curr Med Chem, 2008, 15 (13): 1288 -1296.
  • 9Scirica BM, Cannon CP, Sabatine MS, et al. Concemrations of C - reactive protein and B - type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death [J]. Clin Chem, 2009, 55 (2) : 265 -273.
  • 10Staub D, Morqenthaler NG, Buser C, et al. Use of Copeptin in the detection of myocardial ischemia [ J ]. Clin Chim Acta, 2009, 399 (1/2) : 69 -73.

共引文献70

同被引文献10

引证文献1

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部